Compare Enbridge Inc (ENB) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enbridge Inc vs Tenet Healthcare Corporation — how do they compare? Enbridge Inc trades at $46.45 (market cap $103.38B), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Enbridge Inc is far larger — about 4.9× Tenet Healthcare Corporation's market cap, and Enbridge Inc pays a 6.02% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Enbridge Inc for 91 Days and Tenet Healthcare Corporation for 15 Days on average.
| ENB | THC | |
|---|---|---|
Market Cap | $103.38B | $20.98B |
Volume | 3,684,305 | 428,008 |
Sector | Energy | Health |
52-Week High | $58.04 | $280.77 |
52-Week Low | $45.23 | $161.37 |
Typical Hold Time | 91 Days | 15 Days |
Enterprise Value | $185.39B | $32.06B |
Dividend Yield | 6.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enbridge (ENB) trades at $45.89, down 1.4% with bearish technical signals despite strong fundamentals. The company reported Q2 2026 EPS of $0.46, beating expectations by 7%, and maintains a 6% dividend yield. Revenue grew to $65.19B in 2025 with net income of $7.49B, though 2026 projections show margin compression. Analyst consensus is mixed with 48% buy ratings and a $61.63 price target suggesting 34% upside potential.
ENB presents a value opportunity with discounted valuation metrics (P/E 25.27, P/S 1.72) and stable cash flows, but faces headwinds from rising interest rates and energy market volatility. The stock's current technical weakness contrasts with fundamental strength, creating potential for recovery if operational execution continues to outperform expectations.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
